Reaction
Alternaria Infection reporting signals
As of the last recalculation, Alternaria Infection appears in 363 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is TACROLIMUS OINTMENT 0.1% (PRR 277.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tacrolimus Ointment 0.1% | 227 | 277.3 | 277.8 |
| Tacrolimus Extended-Release Capsules | 227 | 276.6 | 277.1 |
| Tacrolimus | 236 | 245.1 | 245.5 |
| Itraconazole | 24 | 126.1 | 126.4 |
| Mycophenolate Mofetil | 164 | 125.5 | 125.6 |
| Mycophenolate Mofetil Hydrochloride | 164 | 125.2 | 125.4 |
| Voriconazole Injection | 34 | 99.0 | 99.1 |
| Mycophenilic Acid | 32 | 97.0 | 97.2 |
| Busulfan | 23 | 89.4 | 89.5 |
| Voriconazole | 34 | 70.7 | 70.8 |
| Basiliximab | 13 | 65.7 | 65.8 |
| Mycophenolic Acid | 32 | 62.8 | 62.8 |
| Micafungin Sodium | 9 | 62.4 | 62.5 |
| Fluticasone Furoate | 10 | 48.6 | 48.7 |
| Sirolimus | 10 | 43.7 | 43.8 |
| Fludarabine Phosphate | 27 | 42.5 | 42.5 |
| Valganciclovir Hydrochloride Powder, | 8 | 38.4 | 38.5 |